Results: 13
Direct stroke unit admission of intravenous tissue plasminogen activator: safety, clinical outcome, and hospital cost savings.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 304, doi. 10.1177/1756285616648061
- By:
- Publication type:
- Article
Quantitative analysis of multiple sclerosis patients’ preferences for drug treatment: a best–worst scaling study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 287, doi. 10.1177/1756285616648060
- By:
- Publication type:
- Article
Immunoadsorption in patients with neuromyelitis optica spectrum disorder.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 281, doi. 10.1177/1756285616646332
- By:
- Publication type:
- Article
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 269, doi. 10.1177/1756285616643892
- By:
- Publication type:
- Article
Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson’s disease with D-penicillamine treatment failure.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 310, doi. 10.1177/1756285616641598
- By:
- Publication type:
- Article
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 336, doi. 10.1177/1756285616641583
- By:
- Publication type:
- Article
Web-based interventions in multiple sclerosis: the potential of tele-rehabilitation.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 327, doi. 10.1177/1756285616640684
- By:
- Publication type:
- Article
Dimethyl fumarate may still have a role in progressive multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 344, doi. 10.1177/1756285616640396
- By:
- Publication type:
- Article
Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 297, doi. 10.1177/1756285616637046
- By:
- Publication type:
- Article
One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 264, doi. 10.1177/1756285616636551
- By:
- Publication type:
- Article
The diagnosis and management of idiopathic intracranial hypertension and the associated headache.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 317, doi. 10.1177/1756285616635987
- By:
- Publication type:
- Article
Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 250, doi. 10.1177/1756285616634247
- By:
- Publication type:
- Article
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 4, p. 239, doi. 10.1177/1756285616633967
- By:
- Publication type:
- Article